Public Profile

Contract Pharmaceuticals Limited

Contract Pharmaceuticals Limited, commonly referred to as CPL, is a leading contract manufacturer based in Canada, with its headquarters strategically located in Ontario. Founded in 1997, CPL has established itself within the pharmaceutical industry, specialising in the development and production of high-quality pharmaceutical products, including solid dose forms, liquids, and semi-solids. With a commitment to innovation and quality, CPL serves a diverse clientele across North America and beyond, offering tailored solutions that meet stringent regulatory standards. The company’s state-of-the-art facilities and experienced team enable it to deliver unique formulations and efficient production processes, setting it apart in a competitive market. Notable achievements include successful partnerships with various pharmaceutical companies, reinforcing its position as a trusted provider in the contract manufacturing sector.

DitchCarbon Score

How does Contract Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Contract Pharmaceuticals Limited's score of 23 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Contract Pharmaceuticals Limited's reported carbon emissions

Contract Pharmaceuticals Limited, headquartered in Canada, currently does not have available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential for Contract Pharmaceuticals Limited to establish clear climate commitments and reduction initiatives to align with industry standards and expectations. This would not only enhance their sustainability profile but also demonstrate a proactive approach to mitigating climate change impacts.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Contract Pharmaceuticals Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Contract Pharmaceuticals Limited is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Contract Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers